metformin and 5-imidazolepropionic acid

metformin has been researched along with 5-imidazolepropionic acid in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (100.00)	2.80

Authors

Authors	Studies
Bäckhed, F; Koh, A; Mannerås-Holm, L; Molinaro, A; Nilsson, PM; Perkins, R; Ryu, SH; Smith, JG; Yunn, NO	1
Ogawa, W; Sugawara, K	1

Other Studies

2 other study(ies) available for metformin and 5-imidazolepropionic acid

Article	Year
Microbial Imidazole Propionate Affects Responses to Metformin through p38γ-Dependent Inhibitory AMPK Phosphorylation. Cell metabolism, 2020, 10-06, Volume: 32, Issue:4 Topics: AMP-Activated Protein Kinases; Animals; Cell Line; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Imidazoles; Injections, Intraperitoneal; Male; Metformin; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 12; Phosphorylation	2020
The gut microbial metabolite imidazole propionate inhibits metformin action. Journal of diabetes investigation, 2021, Volume: 12, Issue:8 Topics: Diabetes Mellitus, Type 2; Diet; Gastrointestinal Microbiome; Humans; Hypoglycemic Agents; Imidazoles; Metformin	2021

Article

Year

Microbial Imidazole Propionate Affects Responses to Metformin through p38γ-Dependent Inhibitory AMPK Phosphorylation.

Cell metabolism, 2020, 10-06, Volume: 32, Issue:4

Topics: AMP-Activated Protein Kinases; Animals; Cell Line; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Imidazoles; Injections, Intraperitoneal; Male; Metformin; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 12; Phosphorylation

2020

The gut microbial metabolite imidazole propionate inhibits metformin action.

Journal of diabetes investigation, 2021, Volume: 12, Issue:8

Topics: Diabetes Mellitus, Type 2; Diet; Gastrointestinal Microbiome; Humans; Hypoglycemic Agents; Imidazoles; Metformin

2021